GS vs SERA · P/E 20, $324.25B cap vs rev $77.0K
Goldman Sachs Group Inc (GS) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
GS does not have a complete income-statement cache yet.
Latest reported SERA revenue for 2024-12-31 was $77.0K. Net income was -$32.9M. Revenue was down 74.8% from 2023-12-31 to 2024-12-31. SERA currently screens at market cap $89.1M.
GS currently screens at market cap $324.25B and trailing P/E 20.1. SERA currently screens at market cap $89.1M.
Not investment advice. Open the GS and SERA stock pages for the full models.
Not investment advice.